AdjuTec Pharma AS is a Norwegian pharmaceutical start-up company that was founded in 2019 based on research in antibiotic products at the University of Oslo (UoO), Norway.
The company vision is to provide novel antibiotic resistance breakers to meet the imminent threat to modern medicine of antimicrobial resistance (AMR).
AdjuTec's core technology is synthesis of β-lactamase inhibitors (BLIs) that inactivates bacteria resistance enzymes. By taking down bacteria defense we are able to preserve susceptibility of broad-spectrum antibiotics.
Supported by national and EU-grants as well as private funding AdjuTec has started preclinical development of its lead product APC148.
The company vision is to provide novel antibiotic resistance breakers to meet the imminent threat to modern medicine of antimicrobial resistance (AMR).
AdjuTec's core technology is synthesis of β-lactamase inhibitors (BLIs) that inactivates bacteria resistance enzymes. By taking down bacteria defense we are able to preserve susceptibility of broad-spectrum antibiotics.
Supported by national and EU-grants as well as private funding AdjuTec has started preclinical development of its lead product APC148.
Location: Norway, Oslo
Employees: 1-10
Founded date: 2019
Investors 2
| Date | Name | Website |
| 27.01.2023 | Planet 9 C... | planet9ven... |
| - | Farvatn Ve... | farvatnven... |
Mentions in press and media 3
| Date | Title | Description |
| 30.04.2025 | AdjuTec Pharma’s APC148 shines at ESCMID congress | AdjuTec Pharma’s APC148 shines at ESCMID congress Wed, Apr 30, 2025 09:32 CET Report this content At the recent ESCMID congress, organised by the European Society of Clinical Microbiology and Infectious Diseases, AdjuTec Pharma presented a ... |
| 25.02.2025 | AdjuTec Pharma’s CEO to BioStock: “Our goal is to set a new standard in antibiotic treatment” | AdjuTec Pharma’s CEO to BioStock: “Our goal is to set a new standard in antibiotic treatment” Tue, Feb 25, 2025 08:28 CET Report this content Late last year, AdjuTec Pharma launched a phase I clinical trial for its lead candidate, APC148, t... |
| 29.05.2023 | Find your next investment at the BioStock Life Science Spring Summit on May 30 and 31! | Find your next investment at the BioStock Life Science Spring Summit on May 30 and 31! Mon, May 29, 2023 09:45 CET Report this content It is finally time for BioStock Life Science Spring Summit 2023! Around 30 companies from a wide range of... |